Fallopian Tube Adenocarcinoma
NCI Definition: An adenocarcinoma that arises from the fallopian tube. Histologic subtypes include clear cell, endometrioid, serous, and mucinous adenocarcinoma. It spreads to adjacent organs, regional lymph nodes, and peritoneum. 
There are 7 clinical trials for fallopian tube adenocarcinoma, of which 6 are open and 1 is completed or closed. Of the trials that contain fallopian tube adenocarcinoma as an inclusion criterion, 2 are phase 1 (2 open) and 5 are phase 1/phase 2 (4 open).
Carboplatin, paclitaxel, and anlotinib are the most common interventions in fallopian tube adenocarcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.